Trending

people

Sanofi appoints new chief digital officer in C-Suite revamp

Sanofi appoints new chief digital officer in C-Suite revamp

Sanofi’s new CEO Paul Hudson has completed his revamp of the company’s executive committee, including the appointment of

X

Sanofi appoints new chief digital officer in C-Suite revamp

https://pharmaphorum.com/news/sanofi-appoints-new-chief-digital-officer-in-management-revamp/

Roche’s CMO Horning to retire, Lilly’s high-flyer Garraway steps in

Roche’s CMO Horning to retire, Lilly’s high-flyer Garraway steps in

Roche’s influential chief medical officer Sandra Horning is to retire at the end of the year, the company

X

Roche’s CMO Horning to retire, Lilly’s high-flyer Garraway steps in

https://pharmaphorum.com/news/roches-cmo-horning-to-retire/

Gilead’s R&D chief to step down as new CEO O’Day rings the changes

Gilead’s R&D chief to step down as new CEO O’Day rings the changes

Gilead’s chief scientific officer, John McHutchison is to leave the company at the beginning of next month during

X

Gilead’s R&D chief to step down as new CEO O’Day rings the changes

https://pharmaphorum.com/news/gileads-rd-chief-to-step-down-as-new-ceo-oday-rings-the-changes/

Cancer doctor Sharpless to take reins at FDA next month

Cancer doctor Sharpless to take reins at FDA next month

The director of the US National Cancer Institute, Norman “Ned” Sharpless has been announced as the acting FDA

X

Cancer doctor Sharpless to take reins at FDA next month

https://pharmaphorum.com/news/cancer-doctor-sharpless-to-take-reins-at-fda-next-month/

GSK’s chairman Sir Philip Hampton steps down

GSK’s chairman Sir Philip Hampton steps down

GlaxoSmithKline is searching for a new chairman after Sir Philip Hampton announced he is to step down in

X

GSK’s chairman Sir Philip Hampton steps down

https://pharmaphorum.com/news/gsks-chairman-sir-philip-hampton-steps-down/

Solomon quits as Akari CEO following credit card probe

Solomon quits as Akari CEO following credit card probe

Biotech veteran quits after less than a year in charge

X

Solomon quits as Akari CEO following credit card probe

https://pharmaphorum.com/news/solomon-quits-as-akari-ceo-following-credit-card-probe/

After missing out on CEO job, Novo’s US head quits

After missing out on CEO job, Novo’s US head quits

The pressure on Novo Nordisk’s diabetes portfolio is mounting in the US – and the situation seems even

X

After missing out on CEO job, Novo’s US head quits

https://pharmaphorum.com/news/missing-ceo-job-novos-us-head-quits/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com